asa guidelines for glp-1 GLP-1s are changing what we see chairside—and most of us were never taught what to do about it. 🦷⁠ ⁠ Dry mouth. Increased caries risk. Muscle loss. Nutrient deficiencies. Reflux. Your patients How should GLP-1 receptor agonists

JAMA (2014) 311(17):177886

I would break it down into two main categories of safety concerns, says Weber

This study aims to address these gaps by conducting a comprehensive temporal proteomic analysis of iHLOs at four critical stages of development: Days 7, 15, 30, and 45

Similarly, mice lacking the melanocortin-4 receptor eat primarily fat and are unaffected by MT-2

The most highly associated SNP, rs2880961, had a permutation p value of 0.1542, with a q value of 0.107

One in three Canadians are currently living with obesity, and in 10 years, that number is going to change to about 50 per cent, so this is really an opportunity for policymakers to take action. LISTEN | WHO conditionally recommends GLP-1 drugs for obesity: The WHOs first conditional recommendation advises the use of GLP-1 drugs by adults, except pregnant women, for long-term obesity treatment, while the second suggests interventions like a healthy diet and physical activity to be offered alongside the medicines